Login

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma 00:00:00

Share On Facebook Share On Twitter

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Market Momentum and Economic Risks in 2024
00:10:00
In-Depth C-Suite Interview with ACCO Brands CEO Boris Elisman | Boris Elisman, CEO , ACCO Brand.
00:10:00
Dato' Lee's Insider Perspectives: Unveiling the Visionary Mind behind Matrix Concept Holdings Berhad
00:10:00
A global freight forwarder and logistics platform using modern software to fix the user experience|Ryan Petersen,CEO,Flexport Fund
00:00:00
Dr. Amy Seegmiller Renner, ,Assistant Professor, Mayo Clinic
00:00:00
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)
00:10:00
Guiana Gold Strike: Unveiling Opportunities in the Marudi Gold Project
00:10:00
Revolutionizing Biotechnology: The Impact of Directed Evolution Technology on Protein Skins
00:10:00
A global interactive entertainment venture capital firm focused on early stage investments|Michael Cheung,Founding General Partner,Makers Fund
00:10:00
Goldman Sachs Podcast Disclaimer: No Investment Advice or Client Relationship
00:10:00
Finding the Best Investment Strategy for You | Adam Taylor, CEO, Taylor Financial.
00:10:00
Driving Growth and Integration: Bushveld Minerals' Strategic Initiatives Across Commodity Platforms

© 2017 - Neuhu+